Focus: JCR Pharmaceuticals is a Japan-based specialty pharma company focused on recombinant DNA technology and BBB-crossing antibodies for rare neurological disorders, particularly lysosomal storage diseases.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Hot — 31 jobs added in 30d
Net +31 (31 new, 0 removed). Aggressive expansion phase.
JCR is a niche, pipeline-rich rare disease specialist where you could build deep expertise in BBB-crossing biologics, but severely limited hiring and opaque financials create significant uncertainty around career stability and growth opportunity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for JCR Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from JCR Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles